RECORDED MAJOR ADVERSE CARDIOVASCULAR EVENT STATUS AND MORTALITY AMONG PATIENTS HOSPITALIZED WITH COVID-19 IN MACEDONIA: A RETROSPECTIVE ROUTINE-DATA ANALYSIS

  • Nikolina Grozdanovska Faculty of Medical Sciences, Goce Delcev University – Stip, North Macedonia
  • Ivica Smokovski Faculty of Medical Sciences, Goce Delcev University - Stip, Stip, Macedonia; University Clinic of Endocrinology, Diabetes and Metabolic Disorders, Skopje, Macedonia http://orcid.org/0000-0001-6814-1748
  • Svetlana Cekovska Institute of Medical and Experimental Biochemistry, Faculty of Medicine, Ss. Cyril and Methodius University, Skopje, Macedonia http://orcid.org/0000-0001-7152-1725

Abstract

Introduction: Routine health records can support mortality stratification, but uncertain outcome timing limits clinical interpretation. We developed and internally validated a model for recorded death after coronavirus disease 2019 hospitalization. Material and Methods: This retrospective cohort used 33,469 Moj Termin records for patients hospitalized in Macedonia from March 2020 through March 2023. After consolidation, 31,322 unique patients remained; 31,321 entered complete-case modeling. Predictors were non-linear age, sex, and a restricted Charlson Comorbidity Index. Performance was assessed using discrimination, Brier score, calibration, and 500 bootstrap resamples. Major adverse cardiovascular events were examined only in a secondary extension. Results: Death was recorded in 9,385 patients (30.0%). The apparent area under the curve was 0.781 (95% confidence interval, 0.776-0.787); the optimism-corrected value was 0.781. Apparent and corrected Brier scores were 0.1647, and the corrected calibration slope was 0.999. Adding major adverse cardiovascular events increased the area under the curve by 0.0006 (95% confidence interval, 0.0002-0.0009). Conclusion: The model showed stable internal performance for administrative risk stratification. It does not estimate time-specific or in-hospital mortality because a uniform follow-up horizon could not be reconstructed. External temporal and geographic validation is required before clinical use.

References

1. Benchimol EI, Smeeth L, Guttmann A, Harron K, Moher D, Petersen I, et al. The REporting of studies Conducted using Observational Routinely-collected health Data (RECORD) statement. PLoS Med. 2015;12(10):e1001885. doi:10.1371/journal.pmed.1001885.
2. von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP; STROBE Initiative. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement. BMJ. 2007;335(7624):806-808. doi:10.1136/bmj.39335.541782.AD.
3. Bosco E, Hsueh L, McConeghy KW, Gravenstein S, Saade E. Major adverse cardiovascular event definitions used in observational analysis of administrative databases: a systematic review. BMC Med Res Methodol. 2021;21(1):241. doi:10.1186/s12874-021-01440-5.
4. Quan H, Sundararajan V, Halfon P, Fong A, Burnand B, Luthi JC, et al. Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care. 2005;43(11):1130-1139. doi:10.1097/01.mlr.0000182534.19832.83.
5. Harrell FE Jr, Lee KL, Mark DB. Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med. 1996;15(4):361-387. doi:10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4.
6. Steyerberg EW, Vickers AJ, Cook NR, Gerds T, Gonen M, Obuchowski N, et al. Assessing the performance of prediction models: a framework for traditional and novel measures. Epidemiology. 2010;21(1):128-138. doi:10.1097/EDE.0b013e3181c30fb2.
7. Van Calster B, McLernon DJ, van Smeden M, Wynants L, Steyerberg EW. Calibration: the Achilles heel of predictive analytics. BMC Med. 2019;17:230. doi:10.1186/s12916-019-1466-7.
8. Barros AJD, Hirakata VN. Alternatives for logistic regression in cross-sectional studies: an empirical comparison of models that directly estimate the prevalence ratio. BMC Med Res Methodol. 2003;3:21. doi:10.1186/1471-2288-3-21.
9. Zou G. A modified Poisson regression approach to prospective studies with binary data. Am J Epidemiol. 2004;159(7):702-706. doi:10.1093/aje/kwh090.
10. Reyes LF, Garcia-Gallo E, Murthy S, Fuentes YV, Serrano CC, Ibáñez-Prada ED, et al. Major adverse cardiovascular events (MACE) in patients with severe COVID-19 registered in the ISARIC WHO clinical characterization protocol: a prospective, multinational, observational study. J Crit Care. 2023;77:154318. doi:10.1016/j.jcrc.2023.154318.
11. Ali AS, Sheikh D, Chandler TR, Furmanek S, Huang J, Ramirez JA, et al. Cardiovascular complications are the primary drivers of mortality in hospitalized patients with SARS-CoV-2 community-acquired pneumonia. Chest. 2023;163(5):1051-1060. doi:10.1016/j.chest.2022.11.013.
12. Peckham H, de Gruijter NM, Raine C, Radziszewska A, Ciurtin C, Wedderburn LR, et al. Male sex identified by global COVID-19 meta-analysis as a risk factor for death and ITU admission. Nat Commun. 2020;11(1):6317. doi:10.1038/s41467-020-19741-6.
13. Docherty AB, Harrison EM, Green CA, Hardwick HE, Pius R, Norman L, et al. Features of 20,133 UK patients in hospital with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study. BMJ. 2020;369:m1985. doi:10.1136/bmj.m1985.
Published
2026-11-18
How to Cite
GROZDANOVSKA, Nikolina; SMOKOVSKI, Ivica; CEKOVSKA, Svetlana. RECORDED MAJOR ADVERSE CARDIOVASCULAR EVENT STATUS AND MORTALITY AMONG PATIENTS HOSPITALIZED WITH COVID-19 IN MACEDONIA: A RETROSPECTIVE ROUTINE-DATA ANALYSIS. Journal of Morphological Sciences, [S.l.], v. 9, n. 3, p. 57-65, nov. 2026. ISSN 2545-4706. Available at: <https://jms.mk/jms/article/view/vol9no3-7>. Date accessed: 18 nov. 2026.
Section
Articles